Red blood cell erythropoietin, not plasma erythropoietin, concentrations correlate with changes in hematological indices in horses receiving a single dose of recombinant human erythropoietin by subcutaneous injection

Journal of Veterinary Pharmacology and Therapeutics

Volumn 30, Issue 2, 2007, Pages 175-178

  Singh, A K ^a   Gupta, S ^a   Barnes, A ^a   Carlson, J M ^a   Ayers, J K ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN ANTIBODY; ERYTHROPOIETIN RECEPTOR; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; ERYTHROCYTE; ERYTHROCYTE COUNT; ERYTHROCYTE MEMBRANE; ERYTHROCYTE VOLUME; FEMALE; HORSE; MOLECULAR PROBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; DNA PRIMERS; ERYTHROCYTE COUNT; ERYTHROCYTES; ERYTHROPOIESIS; ERYTHROPOIETIN; FEMALE; HORSES; INJECTIONS, SUBCUTANEOUS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EQUIDAE;

EID: 33847610999     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00828.x     Document Type: Article

References (16)

1. Clegg, J.B. (1987) Can the product of the theta gene be a real globin? Nature, 329, 465-466.
2. Cooper, C., Sears, W. & Bienzle, D. (2005) Reticulocyte changes after experimental anemia and erythropoietin treatment of horses. Journal of Applied Physiology, 99, 915-921.
3. Elliott, S., Egrie, J., Browne, J., Lorenzini, T., Busse, L., Rogers, N. & Ponting, I. (2004) Control of rHuEPO biological activity: the role of carbohydrate. Experimental Hematology, 32, 1146-1155.
4. Farnandez, F.R. & Grindem, C.B. (2000) Reticulocyte response. In Schalm's Veterinary Hematology, Eds Feldman, B.F., Zinkl, J.G. & Jain, N.C., pp. 110-116. Lipincott, Philadelphia, PA.
5. Flint, J., Taylor, A.M. & Clegg, J.B. (1988) Structure and evolution of the horse zeta globin locus. Journal of Molecular Biology, 199, 427-437.
6. Ghezzi, P. & Brines, M. (2004) Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death & Differentiation, 11, S37-S44.
7. Gross, A.W. & Lodish, H.F. (2006) Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP). Journal of Biological Chemistry, 281, 2024-2032.
8. Koepke, J.F. & Koepke, J.A. (1986) Reticulocytes. Clinical & Laboratory Haematology, 8, 169-179.
9. Lacombe, C. & Mayeux, P. (1998) Biology of erythropoietin. Haematologica, 83, 724-732.
10. Macdougall, I.C., Gray, S.J., Elston, O., Breen, C., Jenkins, B., Browne, J. & Egrie, J. (1999) Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients. Journal of the American Society of Nephrology, 10, 2392-2395.
11. Mulcahy, L. (2001) The erythropoietin receptor. Seminars in Oncology, 28 (Suppl. 8), 19-23.
12. Parisotto, R., Ashenden, M.J., Gore, C.J., Sharpe, K., Hopkins, W. & Hahn, A.G. (2003) The effect of common hematologic abnormalities on the ability of blood models to detect erythropoietin abuse by athletes. Haematologica, 88, 931-940.
13. Piercy, R.J., Swardson, C.J. & Hinchcliff, K.W. (1998) Erythroid hypoplasia and anemia following administration of recombinant human erythropoietin to two horses. Journal of the American Veterinary Medical Association, 212, 244-247.
14. Romero, A.J., Carbia, C.D., Ceballo, M.F. & Diaz, N.B. (1999) Red cell distribution width (RDW): its use in the characterization of microcytic and hypochromic anemias. Medicina, 59, 17-22.
15. Tilbrook, P.A. & Klinken, S.P. (1999) Erythropoietin and erythropoietin receptor. Growth Factors, 17, 25-35.
16. Walrafen, P., Verdier, F., Kadri, Z., Chretien, S., Lacombe, C. & Mayeux, P. (2005) Both proteasomes and lysosomes degrade the activated erythropoietin receptor. Blood, 105, 600-608.